Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Shares, No Par Value
-
Shares outstanding
-
374M
-
Number of holders
-
303
-
Total 13F shares, excl. options
-
224M
-
Shares change
-
-3.12M
-
Total reported value, excl. options
-
$3.48B
-
Value change
-
-$62.7M
-
Put/Call ratio
-
1.11
-
Number of buys
-
147
-
Number of sells
-
-135
-
Price
-
$15.54
Significant Holders of Bausch Health Companies Inc. - Common Shares, No Par Value (BHC) as of Q3 2020
382 filings reported holding BHC - Bausch Health Companies Inc. - Common Shares, No Par Value as of Q3 2020.
Bausch Health Companies Inc. - Common Shares, No Par Value (BHC) has 303 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 224M shares
of 374M outstanding shares and own 59.79% of the company stock.
Largest 10 shareholders include PAULSON & CO. INC. (25.8M shares), ValueAct Holdings, L.P. (17.9M shares), GLENVIEW CAPITAL MANAGEMENT, LLC (15M shares), PRICE T ROWE ASSOCIATES INC /MD/ (10.8M shares), VANGUARD GROUP INC (9.12M shares), MORGAN STANLEY (7.58M shares), GOLDENTREE ASSET MANAGEMENT LP (7.13M shares), Kohlberg Kravis Roberts & Co. L.P. (5.24M shares), Permian Investment Partners, LP (5.15M shares), and ROYAL BANK OF CANADA (4.9M shares).
This table shows the top 303 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.